Distinct immunomodulation by autoimmunogenic xenobiotics in susceptible and resistant mice

Citation
R. Albers et al., Distinct immunomodulation by autoimmunogenic xenobiotics in susceptible and resistant mice, TOX APPL PH, 160(2), 1999, pp. 156-162
Citations number
28
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGY AND APPLIED PHARMACOLOGY
ISSN journal
0041008X → ACNP
Volume
160
Issue
2
Year of publication
1999
Pages
156 - 162
Database
ISI
SICI code
0041-008X(19991015)160:2<156:DIBAXI>2.0.ZU;2-K
Abstract
HgCl2 and diphenylhydantoin (DPH) are prototype chemicals associated with d iverse (auto)immune effects in genetically susceptible individuals. Both ch emicals activate T cells, and the balance of Th1 versus Th2 activation may influence the clinical outcome of exposure. It is unknown which chemically created neoantigens are responsible for Th activation. We therefore investi gated the effect of DPH and HgCl2 on specific responses to TNP-ovalbumin, i n mouse strains with varying sensitivity for the adverse effects. HgCl2 was found to enhance Th2-driven antibody responses in susceptible B10.s, but p rotective type 1 responses in resistant B10.d2 mice, This was chemical-spec ific, as DPH enhanced type 2 responses in both strains. DBA/2 mice were rel atively unresponsive to HgCl2, whereas DPH stimulated type 1 responses in t hese mice, Interestingly, prior exposure to HgCl2, but not DPH, facilitated IC deposition in B10.s mice only, Thus, we demonstrate that, depending on MHC-II and background genes, HgCl2 and DPH preferentially adjuvate type 1 o r type 2 responses. In case of HgCl2, the type of response corresponds with susceptibility to antibody-mediated autoimmunity induced by this chemical. In addition, we demonstrate that, within one strain, different autoimmunog enic chemicals can enhance distinct responses to the Same antigen. (C) 1999 Academic Press.